http://bio2rdf.org/drugbank_resource:DB00872_DB08816_nanopub.RAJbjSZKYVgB8g4H6KNLMO0XVJe-WCvcH9-8h_q4H7IMg#head http://bio2rdf.org/drugbank_resource:DB00872_DB08816_nanopub.RAJbjSZKYVgB8g4H6KNLMO0XVJe-WCvcH9-8h_q4H7IMg http://www.nanopub.org/nschema#hasAssertion http://bio2rdf.org/drugbank_resource:DB00872_DB08816_nanopub.RAJbjSZKYVgB8g4H6KNLMO0XVJe-WCvcH9-8h_q4H7IMg#assertion http://bio2rdf.org/drugbank_resource:DB00872_DB08816_nanopub.RAJbjSZKYVgB8g4H6KNLMO0XVJe-WCvcH9-8h_q4H7IMg http://www.nanopub.org/nschema#hasProvenance http://bio2rdf.org/drugbank_resource:DB00872_DB08816_nanopub.RAJbjSZKYVgB8g4H6KNLMO0XVJe-WCvcH9-8h_q4H7IMg#provenance http://bio2rdf.org/drugbank_resource:DB00872_DB08816_nanopub.RAJbjSZKYVgB8g4H6KNLMO0XVJe-WCvcH9-8h_q4H7IMg http://www.nanopub.org/nschema#hasPublicationInfo http://bio2rdf.org/drugbank_resource:DB00872_DB08816_nanopub.RAJbjSZKYVgB8g4H6KNLMO0XVJe-WCvcH9-8h_q4H7IMg#publicationInfo http://bio2rdf.org/drugbank_resource:DB00872_DB08816_nanopub.RAJbjSZKYVgB8g4H6KNLMO0XVJe-WCvcH9-8h_q4H7IMg http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://bio2rdf.org/drugbank_resource:DB00872_DB08816_nanopub.RAJbjSZKYVgB8g4H6KNLMO0XVJe-WCvcH9-8h_q4H7IMg#assertion http://bio2rdf.org/drugbank:DB00872 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB00872_DB08816 http://bio2rdf.org/drugbank:DB08816 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB00872_DB08816 http://bio2rdf.org/drugbank_resource:DB00872_DB08816 http://purl.org/dc/terms/identifier drugbank_resource:DB00872_DB08816 http://bio2rdf.org/drugbank_resource:DB00872_DB08816 http://purl.org/dc/terms/title DDI between Conivaptan and Ticagrelor - CYP3A4 Inhibitors (Strong) such as conivaptan may decrease serum concentrations of the active metabolite(s) of Ticagrelor. CYP3A4 Inhibitors (Strong) may increase the serum concentration of Ticagrelor. Avoid use of ticagrelor in combination with strong CYP3A4 inhibitors. http://bio2rdf.org/drugbank_resource:DB00872_DB08816 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://bio2rdf.org/drugbank_vocabulary:Drug-Drug-Interaction http://bio2rdf.org/drugbank_resource:DB00872_DB08816 http://www.w3.org/2000/01/rdf-schema#label DDI between Conivaptan and Ticagrelor - CYP3A4 Inhibitors (Strong) such as conivaptan may decrease serum concentrations of the active metabolite(s) of Ticagrelor. CYP3A4 Inhibitors (Strong) may increase the serum concentration of Ticagrelor. Avoid use of ticagrelor in combination with strong CYP3A4 inhibitors. [drugbank_resource:DB00872_DB08816] http://bio2rdf.org/drugbank_resource:DB00872_DB08816_nanopub.RAJbjSZKYVgB8g4H6KNLMO0XVJe-WCvcH9-8h_q4H7IMg#provenance http://bio2rdf.org/drugbank_resource:DB00872_DB08816_nanopub.RAJbjSZKYVgB8g4H6KNLMO0XVJe-WCvcH9-8h_q4H7IMg#assertion http://semanticscience.org/resource/SIO_000253 http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3 http://bio2rdf.org/drugbank_resource:DB00872_DB08816_nanopub.RAJbjSZKYVgB8g4H6KNLMO0XVJe-WCvcH9-8h_q4H7IMg#publicationInfo http://bio2rdf.org/drugbank_resource:DB00872_DB08816_nanopub.RAJbjSZKYVgB8g4H6KNLMO0XVJe-WCvcH9-8h_q4H7IMg#signature.MCwCFDOxaOQXJncR http://purl.org/nanopub/x/hasPublicKey MIIBtzCCASwGByqGSM44BAEwggEfAoGBAP1/U4EddRIpUt9KnC7s5Of2EbdSPO9EAMMeP4C2USZpRV1AIlH7WT2NWPq/xfW6MPbLm1Vs14E7gB00b/JmYLdrmVClpJ+f6AR7ECLCT7up1/63xhv4O1fnxqimFQ8E+4P208UewwI1VBNaFpEy9nXzrith1yrv8iIDGZ3RSAHHAhUAl2BQjxUjC8yykrmCouuEC/BYHPUCgYEA9+GghdabPd7LvKtcNrhXuXmUr7v6OuqC+VdMCz0HgmdRWVeOutRZT+ZxBxCBgLRJFnEj6EwoFhO3zwkyjMim4TwWeotUfI0o4KOuHiuzpnWRbqN/C/ohNWLx+2J6ASQ7zKTxvqhRkImog9/hWuWfBpKLZl6Ae1UlZAFMO/7PSSoDgYQAAoGAETGrDm8R3KfndKRj7ttr3jVhhstI6/2Ey0ER9F5kdx7Hrd6eolq7yWzPzf2H754tdZxICzxYcdawBbL2ZUzFjWwXTNUQC3+e6evKPJyNELubnZcA+8TxIIwicBnw3Ku6mSeI8SUVr5SBV1VeJoSu/ahldv562IdBR8IagmzuT3Y= http://bio2rdf.org/drugbank_resource:DB00872_DB08816_nanopub.RAJbjSZKYVgB8g4H6KNLMO0XVJe-WCvcH9-8h_q4H7IMg#signature.MCwCFDOxaOQXJncR http://purl.org/nanopub/x/hasSignature MCwCFDOxaOQXJncR8PsXgcclTqqwDGTIAhRHhknsNkfVumTWweieLpRThnwgdw== http://bio2rdf.org/drugbank_resource:DB00872_DB08816_nanopub.RAJbjSZKYVgB8g4H6KNLMO0XVJe-WCvcH9-8h_q4H7IMg#signature.MCwCFDOxaOQXJncR http://purl.org/nanopub/x/signedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://bio2rdf.org/drugbank_resource:DB00872_DB08816_nanopub.RAJbjSZKYVgB8g4H6KNLMO0XVJe-WCvcH9-8h_q4H7IMg http://purl.org/dc/terms/created 2018-03-30T11:12:32.752+02:00 http://bio2rdf.org/drugbank_resource:DB00872_DB08816_nanopub.RAJbjSZKYVgB8g4H6KNLMO0XVJe-WCvcH9-8h_q4H7IMg http://purl.org/dc/terms/license https://creativecommons.org/licenses/by-nc/4.0/ http://bio2rdf.org/drugbank_resource:DB00872_DB08816_nanopub.RAJbjSZKYVgB8g4H6KNLMO0XVJe-WCvcH9-8h_q4H7IMg http://purl.org/nanopub/x/hasSignatureElement http://bio2rdf.org/drugbank_resource:DB00872_DB08816_nanopub.RAJbjSZKYVgB8g4H6KNLMO0XVJe-WCvcH9-8h_q4H7IMg#signature.MCwCFDOxaOQXJncR http://bio2rdf.org/drugbank_resource:DB00872_DB08816_nanopub.RAJbjSZKYVgB8g4H6KNLMO0XVJe-WCvcH9-8h_q4H7IMg http://www.w3.org/ns/prov#wasGeneratedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#specializationOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://purl.org/dc/terms/identifier 3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#used https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasAssociatedWith https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasStartedBy http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/dc/terms/isVersionOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/pav/version eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234